MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from maturities
of investments
$50,000K
Proceeds from exercise of
common stock options
$206K
Proceeds from exercise of
common stock warrants
$31K
Net cash provided by
investing activities
$34,519K
Net cash provided by
financing activities
$34K
Canceled cashflow
$15,481K
Canceled cashflow
$203K
Net change in cash
and cash...
-$20,512K
Canceled cashflow
$34,553K
Stock-based compensation
$5,325K
Accounts payable
$4,080K
Prepaid clinical trial
costs
-$3,522K
Amortization of debt issuance
costs and discount
$1,252K
Payment-in-kind interest
$325K
Depreciation
$47K
Purchases of investments
$15,196K
Purchases of property and
equipment
$249K
Purchases of capitalized
software
$36K
Payments for secondary
registration statement costs
$203K
Net cash used in
operating activities
-$55,065K
Canceled cashflow
$14,551K
Net loss
-$52,841K
Accrued clinical trial
costs
-$8,055K
Other accrued
expenses
-$6,858K
Other current assets
$976K
Non-cash interest income
$883K
Non-cash operating lease
expense
-$3K
Back
Back
Cash Flow
Celcuity Inc. (CELC)
Celcuity Inc. (CELC)
source: myfinsight.com